Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium
Tài liệu tham khảo
Norrby, 2006, Low-molecular-weight heparins and angiogenesis, APMIS, 114, 79, 10.1111/j.1600-0463.2006.apm_235.x
Hirsh, 2001, Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety, Chest, 119, 64S, 10.1378/chest.119.1_suppl.64S
Collen, 2000, Unfractioned and low molecular weight heparin affect fibrin structure and angiogenesis in vitro, Cancer Res, 60, 6196
Deryugina, 2008, Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules, Methods Enzymol, 444, 21, 10.1016/S0076-6879(08)02802-4
Ribatti, 2001, Choriallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo, Anat Rec, 264, 317, 10.1002/ar.10021
Bürgermeister, 2002, LAPSvS1, a (1→3)-beta-galactan sulfate and its effect on angiogenesis in vitro and in vivo, Carbohydr Res, 337, 1459, 10.1016/S0008-6215(02)00163-5
Demirci, 2003, Chemical composition of the essential oil of Phlomis linearis Boiss.&Bal., and biological effects on the CAM assay: a safety evaluation, Z Naturforsch C, 58, 826, 10.1515/znc-2003-11-1214
Bobek, 2004, Antitumor and antimetastatic effect of warfarin and heparins, Biomed Pharmacother, 58, 213, 10.1016/j.biopha.2003.11.007
Pride, 2010, Low molecular weight heparin in the catheterization laboratory, 10
Nasir, 2003, The low molecular weight heparin dalteparin sodium inhibits angiogenesis and induces apoptosis in an experimental tumour model, Blood, 102
Fernandez, 2003, Unfractionated heparin (UFH) and a low molecular weight heparin (dalteparin) exhibit antiangiogenic effects using in vitro, ex vivo and in vivo angiogenesis models, Proc Amer Assoc Cancer Res, 44, 698